- About MHRP
- International Network
- Prevention, Care & Treatment
- News & Publications
We're at the forefront of the battle against HIV to protect U.S. troops from infection and to reduce the global impact of the disease.
MHRP research efforts encompass threat assessment and epidemiology, HIV diagnostics, vaccine development and testing, and therapeutics research.
Dr. Jintanat Ananworanich serves as the Associate Director for Therapeutics Research at MHRP. In this role, Dr. Ananworanich oversees adult HIV therapeutic trials as part of the NIH-funded MHRP Clinical Trials Unit under the AIDS Clinical Trials Group. While she joined MHRP in 2014, Dr. Ananworanich and MHRP researchers have collaborated since 2005 as part of the joint HIV research effort between MHRP, the Thai Red Cross AIDS Research Center and the University of Hawaii.
Dr. Ananworanich possesses a wealth of expertise in developing protocols and managing adult and pediatric HIV clinical trials. Over the past decade she has led more than 60 studies including the Staccato treatment interruption study that led to a seminal paper in the Lancet and the NIAID-funded study, PREDICT, on when to start antiretroviral therapy in children. She has more than 170 publications and is currently the principal investigator on the MHRP/NIAID-funded acute HIV infection study, RV254.
Prior to her role at MHRP, Dr. Ananworanich served as the Director of SEARCH and Deputy Director of Scientific Affairs at the HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) at the Thai Red Cross in Bangkok. She will receive her professorship from the University of Amsterdam in 2014.
A noted leader in the field of pediatric HIV and HIV research, Dr. Ananworanich serves as deputy editor for the journal, AIDS Research and Therapy and editor of Open Virology. In addtion to membership on the steering committee of the Pediatric European Network for Treatment of AIDS and the Thai Government Pharmaceutical Advisory Committee, Dr. Jintanat is a member of the ACTG and the IMPAACT HIV Cure committees and co-chairs the acute HIV infection working group of the ACTG and the clinical research working group of the Forum Cure Project.
Dr. Ananworanich received her medical degree from Prince of Songkhla Medical School in Thailand. Following medical school she studied HIV dendritic cells as a volunteer researcher in the lab of Dr. Anthony S. Fauci at the National Institute of Allergy and Infectious Diseases. Dr. Ananworanich went on to complete a pediatric residency at the University of Chicago and fellowships in allergy and immunology clinical and laboratory immunology at Baylor College of Medicine in Houston. In addition, Dr. Ananworanich received her Ph.D. in Medicine from the University of Amsterdam. She is board certified in pediatrics, allergy and immunology, and clinical and laboratory immunology.